More particularly, the former promotes the transformation of cholangiocytes into malignant ones, as well as CCA progression via the miR-637/LY6E pathway, inducing the overexpression of LY6E for the sponging of miR-637 [74,75]. Here, LY6E is linked to cholangiocarcinoma.